Jeet Guram, MD

Recent Work

• 

  Without Reform, Medicare Policies Will Hamstring New Gene Therapies

  It took until the fall of 2020 – three years after FDA approval – for  Medicare to consistently pay an adequate amount for CAR-T therapy.

  By Jeet Guram, MD

  Categorized in

  • Evidence Base